#723968
Providers like you icon
Glaxo Smith Kline #58160081052

Infanrix® Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine, Adsorbed 25 Lf - 10 Lf - 25 mcg / 0.5 mL Injection 0.5 mL

INFANRIX, SYR 25-58-10MG/0.5ML0.5ML (10/PK)

Infanrix® Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine, Adsorbed 25 Lf - 10 Lf - 25 mcg / 0.5 mL Injection 0.5 mL

Infanrix® Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine, Adsorbed 25 Lf - 10 Lf - 25 mcg / 0.5 mL Injection 0.5 mL

Product Specifications

McKesson #

723968

Manufacturer #

58160081052

Brand

Infanrix®

Manufacturer

Glaxo Smith Kline

Country of Origin

Unknown

Application

DTaP Vaccine

Buy American Act (BAA) Compliant

No

Container Type

Prefilled Syringe

Dosage Form

Injection

Generic Drug Code

99206

Generic Drug Name

Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine, Adsorbed

NDC Number

58160081052

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

25 Lf - 10 Lf - 25 mcg / 0.5 mL

Trade Agreement Act (TAA) Compliant

No

Type

Intramuscular

UNSPSC Code

51201631

User

Indicated for People 6 Weeks to 7 Years of Age

Volume

0.5 mL

Features

INFANRIX is a vaccine indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children 6 weeks to 7 years of age
Each 0.5-mL dose is formulated to contain 25 Lf of diphtheria toxoid, 10 Lf of tetanus toxoid, 25 mcg of inactivated pertussis toxin (PT), 25 mcg of filamentous hemagglutinin (FHA), and 8 mcg of pertactin (69 kiloDalton outer membrane protein)
Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)

More Information

SDS